REPL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,005,817.21

Replimune Group Insider Trading History Chart

Replimune Group Share Price & Price History

^$7.72

▲ +0.09 (1.18%)

As of 04/17/2025 02:52 PM ET

Days: 30 | 90 | 365

Replimune Group Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/16/2024	Sushil Patel	CEO	Sell	10,000	$12.42	$124,200.00	202,014
11/18/2024	Konstantinos Xynos	Insider	Sell	7,246	$10.78	$78,111.88	109,885
8/16/2024	Emily Luisa Hill	CFO	Sell	8,938	$10.18	$90,988.84	101,057
6/7/2024	Konstantinos Xynos	Insider	Sell	15,881	$7.50	$119,107.50	117,131
5/16/2024	Andrew Schwendenman	CAO	Sell	2,298	$6.47	$14,868.06	38,238
5/16/2024	Christopher Sarchi	Insider	Sell	2,218	$6.47	$14,350.46	92,252
5/16/2024	Colin A. Love	COO	Sell	17,615	$6.47	$113,969.05	777,345
5/16/2024	Philip Astley-Sparke	Chairman	Sell	37,928	$6.47	$245,394.16	1,487,350
5/16/2024	Robert Coffin	Director	Sell	11,464	$6.47	$74,172.08	1,821,872
5/16/2024	Sushil Patel	CEO	Sell	20,194	$6.47	$130,655.18	212,014
11/16/2023	Konstantinos Xynos	Insider	Sell	7,313	$10.92	$79,857.96	112,714
9/11/2023	Pamela Esposito	Insider	Sell	5,358	$20.01	$107,213.58	263,436
8/22/2023	Pamela Esposito	Insider	Sell	18,600	$20.01	$372,186.00	263,436
8/11/2023	Pamela Esposito	Insider	Sell	1,400	$20.00	$28,000.00	263,436
7/10/2023	Pamela Esposito	Insider	Sell	20,000	$21.58	$431,600.00	263,436
6/13/2023	Tanya Lewis	Insider	Sell	12,860	$24.06	$309,411.60	135,293
5/16/2023	Colin A. Love	COO	Sell	10,775	$18.05	$194,488.75	794,960
5/16/2023	Jean M Franchi	CFO	Sell	11,351	$18.05	$204,885.55	128,748
5/16/2023	Philip Astley-Sparke	CEO	Sell	17,902	$18.05	$323,131.10	1,525,278
5/16/2023	Sushil Patel	Insider	Sell	15,575	$18.05	$281,128.75	154,571
12/9/2022	Pamela Esposito	Insider	Sell	15,000	$25.03	$375,450.00	229,402
5/16/2022	Colin A. Love	COO	Sell	6,324	$14.59	$92,267.16	765,735
5/16/2022	Jean M Franchi	CFO	Sell	3,436	$14.59	$50,131.24	95,099
5/16/2022	Pamela Esposito	Insider	Sell	3,507	$14.59	$51,167.13	229,402
5/16/2022	Philip Astley-Sparke	CEO	Sell	9,632	$14.59	$140,530.88	1,401,080

SEC Filings (Institutional Ownership Changes) for Replimune Group (NASDAQ:REPL)

92.53% of Replimune Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Replimune Group Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/7/2025	GAMMA Investing LLC	8,795	$0.90M	0.0%	+897.2%	0.011%
3/24/2025	Wellington Management Group LLP	1,096,744	$13.28M	0.0%	+352.5%	1.424%
3/18/2025	California State Teachers Retirement System	42,725	$0.52M	0.0%	+25.9%	0.055%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	65,762	$0.80M	0.0%	-19.0%	0.096%
2/17/2025	Woodline Partners LP	854,309	$10.35M	0.1%	+156.6%	1.249%
2/17/2025	Velan Capital Investment Management LP	181,367	$2.20M	1.9%	N/A	0.265%
2/17/2025	Soleus Capital Management L.P.	262,500	$3.18M	0.2%	N/A	0.384%
2/17/2025	Squarepoint Ops LLC	18,482	$0.22M	0.0%	-5.5%	0.027%
2/17/2025	Two Sigma Advisers LP	170,400	$2.06M	0.0%	-9.6%	0.249%
2/17/2025	Two Sigma Investments LP	212,586	$2.57M	0.0%	+18.6%	0.311%
2/17/2025	Tang Capital Management LLC	2,700,000	$32.70M	2.2%	+125.0%	3.946%
2/17/2025	RTW Investments LP	2,065,010	$25.01M	0.4%	+82.1%	3.018%
2/17/2025	Rafferty Asset Management LLC	77,308	$0.94M	0.0%	-23.6%	0.113%
2/17/2025	Redmile Group LLC	4,905,527	$59.41M	4.1%	+2.6%	7.170%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	9,650	$0.12M	0.0%	N/A	0.014%
2/17/2025	Point72 Asset Management L.P.	283,966	$3.44M	0.0%	N/A	0.415%
2/17/2025	ProShare Advisors LLC	20,788	$0.25M	0.0%	+33.8%	0.030%
2/17/2025	Quantinno Capital Management LP	10,455	$0.13M	0.0%	N/A	0.015%
2/17/2025	MPM Bioimpact LLC	950,000	$11.50M	1.6%	N/A	1.388%
2/17/2025	Parkman Healthcare Partners LLC	869,759	$10.53M	1.4%	+13.9%	1.271%
2/17/2025	Nuveen Asset Management LLC	667,634	$8.09M	0.0%	+108.9%	0.976%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	241,570	$2.93M	0.2%	+8.3%	0.353%
2/17/2025	Omega Fund Management LLC	1,975,203	$23.92M	19.9%	-19.8%	2.887%
2/17/2025	Millennium Management LLC	1,189,662	$14.41M	0.0%	+3.0%	1.739%
2/17/2025	J. Goldman & Co LP	112,683	$1.37M	0.0%	+639.5%	0.165%
2/17/2025	Graham Capital Management L.P.	30,180	$0.37M	0.0%	+6.1%	0.044%
2/17/2025	Fcpm Iii Services B.V.	3,970,668	$48.09M	8.2%	-18.4%	5.803%
2/17/2025	D. E. Shaw & Co. Inc.	972,575	$11.78M	0.0%	+12.1%	1.421%
2/17/2025	Deutsche Bank AG	561,561	$6.80M	0.0%	+4.8%	0.821%
2/17/2025	Crestline Management LP	172,202	$2.09M	0.1%	N/A	0.252%
2/17/2025	Braidwell LP	1,477,102	$17.89M	0.5%	-51.9%	2.159%
2/17/2025	Bank of America Corp DE	24,423	$0.30M	0.0%	-77.6%	0.036%
2/17/2025	BNP Paribas Financial Markets	7,167	$87K	0.0%	-52.3%	0.010%
2/17/2025	Algert Global LLC	45,820	$0.56M	0.0%	+7.1%	0.067%
2/14/2025	Boxer Capital Management LLC	1,796,341	$21.75M	1.8%	N/A	2.625%
2/14/2025	Jane Street Group LLC	316,287	$3.83M	0.0%	+20.6%	0.462%
2/14/2025	Freestone Grove Partners LP	11,589	$0.14M	0.0%	N/A	0.017%
2/14/2025	Schonfeld Strategic Advisors LLC	163,300	$1.98M	0.0%	-71.5%	0.239%
2/14/2025	Northern Trust Corp	589,635	$7.14M	0.0%	+7.3%	0.862%
2/14/2025	The Manufacturers Life Insurance Company	194,004	$2.35M	0.0%	+5.3%	0.284%
2/14/2025	Virtus ETF Advisers LLC	5,818	$70K	0.0%	-40.3%	0.009%
2/14/2025	Voya Investment Management LLC	111,066	$1.35M	0.0%	-0.8%	0.162%
2/14/2025	Price T Rowe Associates Inc. MD	10,962,883	$132.76M	0.0%	+11.0%	16.023%
2/14/2025	Dark Forest Capital Management LP	17,816	$0.22M	0.0%	N/A	0.026%
2/14/2025	Diadema Partners LP	114,000	$1.38M	0.6%	N/A	0.167%
2/14/2025	Hsbc Holdings PLC	14,008	$0.18M	0.0%	N/A	0.020%
2/14/2025	Tower Research Capital LLC TRC	6,772	$82K	0.0%	+696.7%	0.010%
2/14/2025	MetLife Investment Management LLC	37,659	$0.46M	0.0%	+7.2%	0.055%
2/14/2025	Nan Fung Group Holdings Ltd	321,746	$3.90M	3.3%	+11.8%	0.470%
2/14/2025	Dimensional Fund Advisors LP	778,163	$9.43M	0.0%	+42.7%	1.137%
2/13/2025	Marshall Wace LLP	896,184	$10.85M	0.0%	N/A	1.310%
2/13/2025	Jump Financial LLC	71,443	$0.87M	0.0%	+95.5%	0.104%
2/13/2025	XTX Topco Ltd	11,337	$0.14M	0.0%	N/A	0.017%
2/13/2025	Barclays PLC	167,329	$2.03M	0.0%	+5.6%	0.245%
2/13/2025	Sterling Capital Management LLC	2,109	$26K	0.0%	+364.5%	0.003%
2/13/2025	Renaissance Technologies LLC	156,936	$1.90M	0.0%	+45.7%	0.229%
2/13/2025	Legal & General Group Plc	59,366	$0.72M	0.0%	+42.1%	0.087%
2/13/2025	Invesco Ltd.	88,006	$1.07M	0.0%	-51.4%	0.129%
2/13/2025	Bank of Montreal Can	12,326	$0.15M	0.0%	-11.3%	0.018%
2/13/2025	Federated Hermes Inc.	4,070	$49K	0.0%	-20.8%	0.006%
2/13/2025	Aster Capital Management DIFC Ltd	8,276	$100K	0.0%	+8,798.9%	0.012%
2/13/2025	Wells Fargo & Company MN	77,371	$0.94M	0.0%	+102.3%	0.113%
2/12/2025	Trexquant Investment LP	194,592	$2.36M	0.0%	-27.0%	0.284%
2/12/2025	Geode Capital Management LLC	1,429,666	$17.32M	0.0%	+0.1%	2.090%
2/12/2025	Alliancebernstein L.P.	440,612	$5.34M	0.0%	-9.9%	0.644%
2/12/2025	Meeder Asset Management Inc.	16,909	$0.21M	0.0%	N/A	0.025%
2/12/2025	Wellington Management Group LLP	1,096,744	$13.28M	0.0%	+352.5%	1.603%
2/12/2025	JPMorgan Chase & Co.	486,609	$5.89M	0.0%	+95.2%	0.711%
2/12/2025	Artisan Partners Limited Partnership	611,013	$7.40M	0.0%	N/A	0.893%
2/11/2025	Corebridge Financial Inc.	30,267	$0.37M	0.0%	-7.0%	0.044%
2/11/2025	Vanguard Group Inc.	3,595,848	$43.55M	0.0%	+3.7%	5.256%
2/11/2025	KLP Kapitalforvaltning AS	12,400	$0.15M	0.0%	N/A	0.018%
2/11/2025	Sei Investments Co.	12,219	$0.15M	0.0%	N/A	0.018%
2/11/2025	American Century Companies Inc.	111,850	$1.36M	0.0%	+32.2%	0.163%
2/11/2025	Rosalind Advisors Inc.	260,000	$3.15M	1.6%	N/A	0.380%
2/11/2025	Teacher Retirement System of Texas	15,603	$0.19M	0.0%	N/A	0.023%
2/10/2025	Swiss National Bank	103,700	$1.26M	0.0%	+57.4%	0.152%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	107,416	$1.30M	0.0%	-16.2%	0.157%
2/7/2025	AlphaQuest LLC	6,404	$78K	0.0%	-52.5%	0.009%
2/6/2025	Arizona State Retirement System	12,894	$0.16M	0.0%	N/A	0.019%
2/6/2025	Victory Capital Management Inc.	44,880	$0.54M	0.0%	N/A	0.066%
2/6/2025	Charles Schwab Investment Management Inc.	508,398	$6.16M	0.0%	+4.9%	0.743%
2/4/2025	Los Angeles Capital Management LLC	34,547	$0.42M	0.0%	-41.0%	0.050%
2/4/2025	Bank of New York Mellon Corp	174,518	$2.11M	0.0%	+7.3%	0.255%
1/31/2025	New York State Common Retirement Fund	43,204	$0.52M	0.0%	+260.8%	0.063%
1/30/2025	Rhumbline Advisers	95,465	$1.16M	0.0%	+8.3%	0.140%
1/24/2025	China Universal Asset Management Co. Ltd.	16,317	$0.20M	0.0%	+24.2%	0.024%
1/17/2025	SG Americas Securities LLC	26,291	$0.32M	0.0%	+14.7%	0.038%
12/26/2024	JPMorgan Chase & Co.	249,349	$2.73M	0.0%	+3.3%	0.364%
11/19/2024	Barclays PLC	158,491	$1.74M	0.0%	+165.5%	0.232%
11/16/2024	Geode Capital Management LLC	1,428,301	$15.66M	0.0%	+17.9%	2.088%
11/15/2024	Barclays PLC	158,491	$1.74M	0.0%	+165.5%	0.232%
11/15/2024	Jane Street Group LLC	262,248	$2.87M	0.0%	-51.1%	0.383%
11/15/2024	Wellington Management Group LLP	242,398	$2.66M	0.0%	-40.2%	0.354%
11/15/2024	State Street Corp	2,340,042	$25.65M	0.0%	+102.1%	3.420%
11/15/2024	Redmile Group LLC	4,781,183	$52.40M	3.1%	-14.0%	6.988%
11/15/2024	Parkman Healthcare Partners LLC	763,747	$8.37M	1.1%	+45.5%	1.116%
11/15/2024	Jacobs Levy Equity Management Inc.	39,521	$0.43M	0.0%	-52.8%	0.058%
11/15/2024	Arizona PSPRS Trust	76,100	$0.83M	0.0%	N/A	0.111%
11/15/2024	Baker BROS. Advisors LP	11,045,336	$121.06M	1.3%	+10.0%	16.143%

Data available starting January 2016

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors; and that has completed Phase II clinical trials for treating cutaneous squamous cell carcinoma. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

Today's Range

Now: $7.72

$7.53

$7.86

50 Day Range

MA: $10.95

$6.92

$14.31

52 Week Range

Now: $7.72

$4.92

$17.00

Volume

289,420 shs

Average Volume

867,123 shs

Market Capitalization

$594.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

Who are the company insiders with the largest holdings of Replimune Group?: Replimune Group's top insider shareholders include:
Robert Coffin (Director)
Philip Astley-Sparke (CEO)
Philip Astley-Sparke (Chairman)
Colin Love (COO)
Pamela Esposito (Insider)
Sushil Patel (CEO)
Sushil Patel (Insider)
Tanya Lewis (Insider)
Jean M Franchi (CFO)
Konstantinos Xynos (Insider)
Emily Luisa Hill (CFO)
Christopher Sarchi (Insider)
Andrew Schwendenman (CAO)
Learn More about top insider investors at Replimune Group.
Who are the major institutional investors of Replimune Group?: Replimune Group's top institutional shareholders include:
GAMMA Investing LLC — 0.01%
Learn More about top institutional investors of Replimune Group stock.
Which institutional investors are buying Replimune Group stock?: During the previous quarter, REPL stock was purchased by institutional investors including:
GAMMA Investing LLC